John W. Smither, Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 1,750 shares at $30.00 ($53K) on 2021-01-19, disclosed to the SEC on 2021-01-21.
Scheduled sale ($52k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 500 | $15K | 28.6% |
| 2 | $30.00 | 1,250 | $38K | 71.4% |
| Total | $30.00 avg | 1,750 | $53K | 100% |
| Filing → |
| GNLX | SELL | 2023-09-14 | $19K | — | Filing → |
| ARQT | SELL | 2021-03-11 | $58K | — | Filing → |
| ARQT | SELL | 2021-03-03 | $26K | — | Filing → |